Building the biopharma company of the future

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of new categories of medicine

Exploring the Brain Immune Gut (BIG) Axis

Focused on the crosstalk and biological processes associated with the brain-immune-gut interface

Giving Life to Science

Our goal is to improve and extend the lives of patients

Moving Medicine Forward

Discovery Reinvented

Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail

Specific components of the microbiota—the microorganisms that normally colonize the body—can affect disease progression in mouse models of arthritis, central nervous system inflammation, diabetes, intestinal inflammation, and obesity.

Full Article
Publications -2017-06-01
Video game training enhances cognitive control in older adults

Cognitive controlis defined by a set of neural processes that allow us to interact with our complex environment in a goal-directed manner.


PureTech Health CEO Daphne Zohar to Present at The Wall Street Journal Health Forum on May 22, 2018 in Washington, D.C.
PureTech's Chief Scientific Officer Joe Bolen to present in keynote, "The Brain-Immune-Gut Super System and the Emergence of Human Chronic Disease" at MIT Lincoln Laboratory Advanced Research and Technology Symposium (ARTS) on March 6, 2018
Media Coverage
CNBC: Opening Bell, February 15, 2018

Ringing today's opening bells are Goodrich Petroleum with Gil Goodrich, chairman and CEO, and Robert Turnham, president, at the NYSE, and resTORbio with Chen Schor, co-founder, president and CEO, and Dr. Joan Mannick, co-founder and CMO, at the Nasdaq.